Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 6.60 ($0.08) and last traded at GBX 6.30 ($0.08), with a volume of 370347 shares changing hands. The stock had previously closed at GBX 6.40 ($0.08).
Allergy Therapeutics Stock Performance
The firm has a market cap of £304.71 million, a P/E ratio of -106.47, a PEG ratio of -30.70 and a beta of 1.40. The company has a quick ratio of 1.48, a current ratio of 1.40 and a debt-to-equity ratio of 37.22. The firm has a fifty day moving average of GBX 5.46 and a 200-day moving average of GBX 5.05.
Allergy Therapeutics Company Profile
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Featured Stories
- Five stocks we like better than Allergy Therapeutics
- How to Buy Cheap Stocks Step by Step
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What does consumer price index measure?
- 2 Drone Stocks Surging from Increased Media Attention
- What Are the U.K. Market Holidays? How to Invest and Trade
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
